SANA
Sana Biotechnology, Inc.NASDAQHealthcare$3.20+4.92%ClosedMarket Cap: $854.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.07
P/S
0.00
EV/EBITDA
-4.73
DCF Value
$-0.03
FCF Yield
-16.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-142.0%
ROA
-58.6%
ROIC
-54.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-1.8M | $-58.8M | $-0.20 | — |
| FY 2025 | $0.00 | -Infinity% | $-191.0M | $-244.2M | $-0.96 | — |
| Q3 2025 | $0.00 | NaN% | $-43.5M | $-42.2M | $-0.16 | — |
| Q2 2025 | $0.00 | NaN% | $-95.0M | $-93.8M | $-0.39 | — |
| Q1 2025 | $0.00 | NaN% | $-50.6M | $-49.4M | $-0.21 | — |
| Q4 2024 | $0.00 | NaN% | $-50.9M | $-49.1M | $-0.21 | — |
| FY 2024 | $0.00 | NaN% | $-272.7M | $-266.8M | $-1.16 | — |
| Q3 2024 | $0.00 | NaN% | $-61.8M | $-59.9M | $-0.25 | — |
| Q2 2024 | $0.00 | NaN% | $-49.4M | $-50.3M | $-0.21 | — |
| Q1 2024 | $0.00 | NaN% | $-110.7M | $-107.5M | $-0.49 | — |
| Q4 2023 | $0.00 | NaN% | $-90.6M | $-88.1M | $-0.45 | — |
| FY 2023 | $0.00 | NaN% | $-293.1M | $-283.3M | $-1.46 | — |